2005 CBCRP Application Evaluation & Review Committees

In the first phase of the funding process, grant applications were reviewed and scored for scientific merit in five peer review committees using a model that follows established practice at the National Institutes of Health (NIH). Each committee is composed of scientists and advocates from outside California. The committee chair leads the review process and is a senior researcher in breast cancer areas associated with the committee’s central topics (e.g., etiology and prevention). Committee members have broad expertise in topics associated with individual applications. Breast cancer advocate reviewers are women and men active in breast cancer issues and many of whom are also living with the disease. Advocates bring their personal knowledge and commitment to the review process. Often they have specialized training in grant review, such as the NBCC’s Project LEAD. Each committee also includes a California Advocate observer, who is not assigned applications for review and does not vote, but represents the California advocacy community. The observer gains insight into the research evaluation process and provides feedback to the Program on this process. Ad Hoc members participate by teleconference and bring their specialized expertise to the review of individual applications.

The majority of research funding agencies rate proposals with a single scientific merit score. For the past eight years the CBCRP has been using a merit scoring system that separates scientific merit into individual components (e.g., approach, innovativeness, impact). This allows our expert reviewers and the Program to better differentiate applications that might otherwise appear identical. For example, we can now pick the most innovative applications, or those that might have the most impact on breast cancer. Depending on the award type, we use four or five scientific merit components in the peer review process.

After the completion of all review committees, the CBCRP ranks the application pool by average scientific merit. The lowest one-third (approximately) of applications, ranked by average scientific merit, are excluded from further consideration for funding.

Next, applications having sufficient scientific merit are rated by the CBCRP’s advisory council for programmatic relevance. The following criteria are used:

• Responsiveness to the CBCRP’s priority issues and award types
• Career plan/mentoring, critical path/translation, or dissemination and translation potential
• Strength of individual scientific merit component scores (e.g., innovation for IDEA applications)
• CBCRP balance or an underfunded topic
• Quality of the lay abstract
• Inclusion of advocates and sensitivity to advocacy issues/concerns

This two-tiered process ensures both scientific excellence and relevance of the research to CBCRP’s mission and goals.

The CBCRP wishes to thank the participants in our 2005 Review Committees for their
service and dedication to our Program.

CRC Concept Paper & CRC-Sociocultural Review Committees

Chair:

Julia H. Rowland, Ph.D.
Adjunct Associate Professor
Department of Psychiatry
Georgetown University School of Medicine
Washington, DC
 

Members:

Michael A. Andrykowski, Ph.D.
Professor of Behavioral Science
University of Kentucky, College of Medicine
Lexington, KY
Bonnie McGregor, Ph.D.
Assistant Member
Fred Hutchinson Cancer Research Center
Seattle, WA
Mary Anglin, Ph.D., M.P.H.
Associate Professor
Department of Anthropology
University of Kentucky
Lexington, KY
Suzanne M. Miller, Ph.D.
Senior Member
Division of Population Science
Fox Chase Cancer Center
Cheltenham, PA
Marilie D. Gammon, Ph.D.
Professor
Department of Epidemiology
University of North Carolina
Chapel Hill, NC
Shiraz I. Mishra, M.D., Ph.D.
Associate Professor
Department of Epidemiology and Preventive Medicine
University of Maryland, Baltimore - School of Medicine
Baltimore, MD
Mel R. Haberman, Ph.D.
Associate Dean for Research and Institutional Outcomes
Intercollegiate College of Nursing
Washington State University
Spokane, WA
Marion E. Morra, Sc.D.
President
Morra Communications
Milford, CT
Kathryn M. Kash, Ph.D.
Associate Professor
Thomas Jefferson University
Department of Psychiatry and Human Behavior
Philadelphia, PA
Deborah K. Padgett, Ph.D., M.P.H.
Professor of Social Work
New York University
New York, NY
Alicia K. Matthews, Ph.D.
Associate Professor
College of Nursing
University of Illinois at Chicago
Chicago, IL
Marc D. Schwartz, Ph.D.
Associate Professor of Oncology
Lombardi Cancer Center, Cancer Control
Georgetown University Medical Center
Washington, DC
  Beti Thompson, Ph.D.
Member
Cancer Prevention Research Unit
Fred Hutchinson Cancer Research Center
Seattle, WA
 

Advocate Members:

Anne-Marie Kunzler
SHARE, NBCC
New York, NY
Kim O'Meara
Mercy Women's Center Advisory Board
Cedar Rapids, IA
Terri O'Hara
Lesbian Cancer Support Services
Kittredge, CO
Jane B. Segelken
Ithaca Breast Cancer Alliance
Ithaca, NY
 

California Advocate Observer:

Sandie Huston
Breast Cancer Action
El Cerrito, CA
 
 

Ad-Hoc Members:

Donald F. Austin, M.D., M.P.H.
Professor
Oregon Health and Science University
Portland, OR
Katherine H. Tkaczuk, M.D.
Associate Professor
University of Maryland, Greenebaum Cancer Center
Baltimore, MD
Mickey Gunter, Ph.D.
Professor
Geological Sciences
University of Idaho
Moscow, ID
George Wright, Ph.D.
Associate Professor
Research Section
University of Washington
Seattle, WA
Nancy Keating, M.D., MPH
Assistant Professor of Medicine and Health Care Policy
Department of Health Care Policy
Harvard Medical School
Boston, MA
Martin J. Yaffe, Ph.D
Professor
Department of Imaging Research
Sunnybrook Health Science Centre
Toronto, Ontario, Canada
Geoff Plumlee, Ph.D.
Research Geochemist
U.S. Geological Survey
Denver Federal Center
Denver, CO
 

Etiology and Prevention Committee

Chair:

Mary S. Wolff, Ph.D.
Professor of Community Medicine
Division of Environmental and Occupational Medicine
Mount Sinai Medical School
New York, NY
 

Members:

Donald F. Austin, M.D., M.P.H.
Professor
Oregon Health and Science University
Portland, OR
Kirsten Moysich, Ph.D.
Associate Professor
Cancer Prevention Epidemiology and Biostatistics
Roswell Park Cancer Institute
Buffalo, NY
Joan E. Cunningham, Ph.D.
Research Assistant Professor
University of South Carolina
Columbia, SC
Vincent Njar, Ph.D,
Associate Professor
Dept. of Pharmacology and Experimental Therapeutics
University of Maryland, School of Medicine
Baltimore, MD
Adrian V. Lee, Ph.D.
Assistant Professor
Breast Center
Baylor College of Medicine
Houston, TX
Karen L. Swisshelm, Ph.D.
Associate Professor
Department of Pathology
University of Washington, School of Medicine
Seattle, WA
Daniel Medina, Ph.D.
Professor
Department of Molecular and Cellular Biology
Baylor College of Medicine
Houston, TX
Patricia A. Thompson, Ph.D.
Assistant Professor
Arizona Cancer Center
Tucson, AZ
 

Advocate Members:

Cecilia Fabrizio
Y-ME
Greenwich, CT
Kimberly Wright
Susan G. Komen Breast Cancer Foundation
Baltimore, MD
 

California Advocate Observer:

Susan Samson
Berkeley, CA
University of California, San Francisco, Breast Cancer SPORE
Berkeley, CA
 
 

Ad-Hoc Members:

 
Electra D. Paskett, Ph.D.
Associate Director of Population Sciences
Ohio State University
Columbus, OH
Daniel Sem, Ph.D.
Assistant Professor
Marquette University
Milwaukee, WI

Innovative Treatments/Earlier Detection Committee

Chair:

Kapil Dhingra, M.D.
Vice President, Oncology
Hoffmann-La Roche
Nutley, NJ

Members:

Gregory P. Adams, Ph.D.
Associate Member
Department of Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA
Michael A. Jacobs, Ph.D.
Assistant Professor of Radiology
Department of Radiology
The Johns Hopkins University School of Medicine
Baltimore, MD
Joseph Baar, M.D., Ph.D.
Assistant Professor
University of Pittsburgh Cancer Institute
Pittsburgh, PA
Francisco J. Esteva, M.D., Ph.D.
Director, Breast Cancer Translational Research Laboratory
Department of Breast Medical Oncology
The University of Texas, MD Anderson Cancer Center
Houston, TX
Ralph J. Bernacki, Ph.D.
Professor; Cancer Research Scientist
Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, NY
Gregory S. Karczmar, Ph.D.
Associate Professor of Radiology
University of Chicago Medical Center
Chicago, IL
Ching-Shih Chen, Ph.D.
Professor
College of Pharmacy
The Ohio State University
Columbus, OH
Rachel E. Klevit, D. Phil.
Professor
Department of Biochemistry
University of Washington
Seattle, WA
Si-Yi Chen, M.D., Ph.D.
Associate Professor
Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX
Brian W. Pogue, Ph.D.
Associate Professor
Thayer School of Engineering
Dartmouth College
Hanover, NH
Timothy M. Clay, Ph.D.
Associate Professor
Department of Surgery
Duke University Medical Center
Durham, NC
Edward R. Sauter, M.D., Ph.D.
Associate Professor
Department of Surgery
University of Missouri-Columbia
Columbia, MO
Billy W. Day, Ph.D.
Associate Professor and Director, Proteomics Core Lab
Department of Pharmaceutical Sciences
University of Pittsburgh
Pittsburgh, PA
David A. Talmage, Ph.D.
Associate Professor of Clinical Nutrition
Columbia University, Institute of Human Nutrition
New York, NY
Stephen L. Eck, M.D., Ph.D.
Executive Director
Pfizer Global Research and Development
Ann Arbor, MI
Nancy S. Templeton, Ph.D.
Assistant Professor
Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX

Zhen Zhang, Ph.D.
Associate Professor & Associate Director
Center for Biomarker Discovery, Dept. of Pathology
Johns Hopkins Medical Institutes
Baltimore, MD

Advocate Member:

Anna Cluxton
Young Survival Coalition
Columbia, MO

Musa Mayer
National Breast Cancer Coalition
New York, NY
Sharon Goodrich
National Breast Cancer Coalition
Fairfax Station, VA
Candice Zito-Gilhooly
Y-ME National Breast Cancer Organization
Cary, IL
 

California Advocate Observer:

Karren Ganstwig
Los Angeles Breast Cancer Alliance
Toluca Lake, CA

Pathogenesis Committee

Chair:

Karin D. Rodland, Ph.D.
Staff Scientist
Molecular Biosciences Division
Pacific Northwest National Laboratory
Richland, WA
 

Members:

C. Marcelo Aldaz, M.D.
Biologist and Professor
M.D. Anderson Cancer Center
University of Texas
Smithville, TX
Steffi Oesterreich, Ph.D.
Associate Professor of Medicine
Breast Center
Baylor College of Medicine
Houston, TX
Gail M. Clinton, Ph.D.
Professor of Biochemistry and Molecular Biology
Oregon Health Sciences University
Portland, OR
Funmi Olopade, M.D.
Associate Professor
Section of Hematology/Oncology
University of Chicago
Chicago, IL
Stephen R. Hann, Ph.D.
Professor and Vice-Chairman
Department of Cell and Developmental Biology
Vanderbilt University School of Medicine
Nashville, TN
W. Jack Pledger, Ph.D.
Professor, Biochemistry and Molecular Biology
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida
Tampa, FL
Shawn E. Holt, Ph.D.
Associate Professor
Department of Pathology
Virginia Commonwealth University
Richmond, VA
Patricia Schoenlein, Ph.D.
Associate Professor
Cellular Biology and Anatomy
Medical College of Georgia
Augusta, GA
Patricia J. Keely, Ph.D.
Assistant Professor
Department of Pharmacology
University of Wisconsin
Madison, WI
Andrew Thorburn, Ph.D.
Associate Professor
Department of Pharmacology
University of Colorado Health Science Center
Aurora, CO
Thomas J. Kelly, Ph.D.
Associate Professor
Department of Pathology
Arkansas Cancer Research Center
Little Rock, AR
Carla Van Den Berg, Pharm.D.
School of Pharmacy
University of Colorado Health Science Center
Denver, CO
Charlotte Kuperwasser, Ph.D.
Assistant Professor
Molecular Oncology Research Institute
Tufts University, School of Medicine
Boston, MA
Alan Wells, M.D. D.M.S.
Professor
Department of Pathology
University of Pittsburgh
Pittsburgh, PA
James Manfredi, Ph.D.
Associate Professor
Derald H. Ruttenberg Cancer Center
Mount Sinai School of Medicine
New York, NY
Bart Williams, Ph.D.
Scientific Investigator
Van Andel Institute
Grand Rapids, MI
James B. McCarthy, Ph.D.
Professor
Lab Medicine and Pathology
University of Minnesota
Minneapolis, MN
 
 

Advocate Members:

Ann E. Fonfa, BPS
The Annie Appleseed Project
Delray Beach, FL
Pat Pangburn
National Breast Cancer Coalition
Irving, TX
Kathleen Harris
Wisconsin Breast Cancer Coalition
Milwaukee, WI
Brian R. Shappell
The Catherine Peachey Fund
Mishawaka, IN
 

California Advocate Observer:

Pamela R. Priano
Breast Cancer Action Group of the Monterey Peninsula
Carmel Valley, CA

Tumor Progression Committee

Chair:

Suzanne A.W. Fuqua, Ph.D.
Professor of Medicine
Breast Center
Baylor College of Medicine
Houston, TX
 

Members:

Adrienne D. Cox, Ph.D.
Associate Professor
Depts. Radiation Oncology and Pharmacology
University of North Carolina at Chapel Hill
Chapel Hill, NC
Rakesh Kumar, Ph.D.
Professor and Deputy Chairman
Department of Molecular and Cellular Oncology
MD Anderson Cancer Center
Houston, TX
Gabriela Dontu, M.D., Ph.D.
Research Investigator
Dept. Internal Medicine, Hematology-Oncology
University of Michigan Medical School
Ann Arbor, MI
Peggy L. Porter, M.D.
Head, Breast Cancer Research Program
Divisions of Human Biology and Public Health Sciences
Fred Hutchinson Cancer Research Center
Seattle, WA
Robin S. L. Fuchs-Young, Ph.D.
Associate Professor
Science Park Research Division
MD Anderson Cancer Center
Smithville, TX
Victoria Seewaldt, M.D.
Associate Professor of Medicine
Duke University Medical Center
Durham, NC
Amy M. Fulton, Ph.D.
Professor
Program in Oncology, Department of Pathology
University of Maryland
Baltimore, MD
Jeffrey E. Segall, Ph.D.
Professor
Department of Anatomy and Structural Biology
Albert Einstein College of Medicine
Bronx, NY
William C. Hahn, M.D., Ph.D.
Assistant Professor of Medicine
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, MA
Stewart Sell, M.D.
Research Physician
New York State Health Department, Wadsworth Center
Albany, NY
Jeffrey T. Holt, M.D.
Todd Professor of Experimental Pathology
University of Colorado Health Sciences Center
Denver, CO
Carolyn L. Smith, Ph.D.
Associate Professor
Department of Molecular and Cellular Biology
Baylor College of Medicine
Houston, TX
Nelson D. Horseman, Ph.D.
Professor
Department of Molecular and Cell Physiology
University of Cincinnati College of Medicine
Cincinnati, OH
Sallie Smith Schneider, Ph.D.
Adjunct Research Assistant Professor
Molecular and Cellular Biology Program
University of Massachusetts
Amherst, MA
Eldon R. Jupe, Ph.D.
Vice President, Research
InterGenetics, Incorporated
Oklahoma City, OK
Katherine H. Tkaczuk, M.D.
Associate Professor
University of Maryland, Greenebaum Cancer Center
Baltimore, MD
Khandan Keyomarsi, Ph.D.
Associate Professor
Experimental Radiation Oncology
MD Anderson Cancer Center
Houston, TX
Ming Zhang, Ph.D.
Assistant Professor
Department of Molecular and Cellular Biology
Baylor College of Medicine
Houston, TX
 

Advocate Members:

Holly Anderson
Breast Cancer Coalition of Rochester
Rochester, NY
Patricia Haugen
National Breast Cancer Coalition
Sioux Falls, SD
Vernal H. Branch
The Virginia Breast Cancer Foundation
Richmond, VA
Ginny Mason, RN
Inflammatory Breast Cancer Research Foundation
Goshen, IN
 

California Advocate Observer:

Debbie Laxague
National Breast Cancer Coalition
Mt. Shasta, CA
 

Ad-Hoc Member:

Robert J. Linhardt, Ph.D.
Professor of Chemistry and Chemical Biology
Rensselaer Polytechnic Institute
Troy, NY